MassMutual Private Wealth & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Buy
115,825
+1,773
+2% +$46.4K 0.07% 175
2026
Q1
$3.2M Sell
114,052
-5,850
-5% -$156K 0.09% 160
2025
Q4
$2.99M Sell
119,902
-9,983
-8% -$252K 0.08% 162
2025
Q3
$3.31M Sell
129,885
-1,256
-1% -$31K 0.08% 166
2025
Q2
$3.18M Sell
131,141
-8,697
-6% -$203K 0.08% 166
2025
Q1
$3.54M Buy
139,838
+5,749
+4% +$150K 0.1% 155
2024
Q4
$3.56M Sell
134,089
-24,791
-16% -$672K 0.1% 152
2024
Q3
$4.6M Sell
158,880
-745
-0.5% -$21.7K 0.13% 145
2024
Q2
$4.47M Sell
159,625
-876
-0.5% -$24.1K 0.14% 140
2024
Q1
$4.45M Sell
160,501
-29,191
-15% -$810K 0.14% 142
2023
Q4
$5.46M Sell
189,692
-47,804
-20% -$1.45M 0.18% 118
2023
Q3
$7.88M Sell
237,496
-9,497
-4% -$336K 0.29% 83
2023
Q2
$9.06M Buy
246,993
+4,386
+2% +$171K 0.33% 78
2023
Q1
$9.9M Buy
242,607
+7,923
+3% +$342K 0.38% 73
2022
Q4
$12M Sell
234,684
-415
-0.2% -$19.9K 0.49% 53
2022
Q3
$10.3M Sell
235,099
-546
-0.2% -$26.5K 0.47% 57
2022
Q2
$12.4M Sell
235,645
-305
-0.1% -$15.5K 0.54% 49
2022
Q1
$12.2M Buy
235,950
+460
+0.2% +$23.9K 0.46% 54
2021
Q4
$13.9M Buy
235,490
+52
+0% +$2.58K 0.52% 46
2021
Q3
$10.1M Sell
235,438
-10
-0% -$443 0.42% 63
2021
Q2
$9.22M Buy
235,448
+2,606
+1% +$101K 0.39% 66
2021
Q1
$8.44M Sell
232,842
-2,235
-1% -$79.4K 0.4% 67
2020
Q4
$8.65M Sell
235,077
-18,846
-7% -$691K 0.44% 53
2020
Q3
$8.84M Sell
253,923
-46,659
-16% -$1.64M 0.52% 49
2020
Q2
$9.32M Sell
300,582
-4,799
-2% -$163K 0.6% 42
2020
Q1
$9.46M Sell
305,381
-6,225
-2% -$212K 0.76% 33
2019
Q4
$11.6M Sell
311,606
-94
-0% -$3.35K 0.72% 34
2019
Q3
$10.6M Sell
311,700
-5,217
-2% -$190K 0.71% 31
2019
Q2
$13M Buy
316,917
+9,707
+3% +$385K 0.9% 22
2019
Q1
$12.4M Sell
307,210
-25,969
-8% -$1.04M 0.89% 24
2018
Q4
$13.8M Buy
333,179
+3,721
+1% +$154K 1.18% 18
2018
Q3
$13.8M Buy
329,458
+2,674
+0.8% +$103K 1.02% 18
2018
Q2
$11.2M Sell
326,784
-561
-0.2% -$19.2K 0.9% 21
2018
Q1
$11M Sell
327,345
-689
-0.2% -$23.7K 0.91% 24
2017
Q4
$11.3M Buy
328,034
+32,756
+11% +$1.12M 0.93% 22
2017
Q3
$10M Buy
295,278
+11,099
+4% +$357K 0.83% 27
2017
Q2
$9.06M Buy
284,179
+57,044
+25% +$1.8M 0.81% 29
2017
Q1
$7.37M Sell
227,135
-47,923
-17% -$1.51M 0.69% 30
2016
Q4
$8.48M Buy
+275,058
New +$8.4M 1.04% 18
2016
Q2
$8.53M Buy
255,479
+21,533
+9% +$687K 1.08% 17
2016
Q1
$6.58M Buy
233,946
+42,029
+22% +$1.2M 0.89% 25
2015
Q4
$5.88M Buy
191,917
+115,162
+150% +$3.62M 0.84% 27
2015
Q3
$2.15M Buy
76,755
+10,367
+16% +$332K 0.45% 60
2015
Q2
$1.87M Sell
66,388
-27,846
-30% -$908K 0.42% 58
2015
Q1
$3.11M Buy
94,234
+23,640
+33% +$752K 0.51% 53
2014
Q4
$2.09M Sell
70,594
-6,161
-8% -$177K 0.67% 38
2014
Q3
$2.15M Buy
76,755
+23,587
+44% +$662K 0.43% 63
2014
Q2
$1.5M Buy
53,168
+13,029
+32% +$371K 0.59% 41
2014
Q1
$1.22M Buy
40,139
+4,150
+12% +$124K 0.72% 38
2013
Q4
$1.05M Buy
+35,989
New +$1.05M 0.96% 23

Other funds holding PFE

MassMutual Private Wealth & Trust's PFE Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $46.4K and bringing the position to 115,825 shares worth $2.79M. The position accounts for 0.07% of the portfolio, ranked #175.

MassMutual Private Wealth & Trust first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.9M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MassMutual Private Wealth & Trust held 115,825 shares of Pfizer worth $2.79M as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 1,773 Pfizer shares in Q2 2026, an estimated $46.4K.
  • Pfizer made up 0.07% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #175 holding.
  • MassMutual Private Wealth & Trust first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • MassMutual Private Wealth & Trust's Pfizer position peaked at $13.9M in Q4 2021.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.